Amarna Therapeutics appointed new CEO
Dutch Amarna Therapeutics has appointed Dr Steen Klysner. The new CEO has been active in the biotech industry for more than 30 years
His predecessor Ben van Leent, Amarna founder and CEO, joined the companys Supervisory Board. Steen brings an extensive background as a biotech CEO to Swedish ExpreS2ion Biotech Holding AB & the Danisch ExpreS2ion Biotechnologies ApS, preceded by an impressive track record in execution and value creation within the biotech industry. His leadership experience makes Steen an ideal candidate to lead Amarna into its next stage of growth and development., said Thomas Eldered, Chairman of Amarnas Supervisory Board. Other stations from Klysner with different management roles were Allergopharma, Nordic Vaccine, and additional positions at Pharmexa, Novo Nordisk and ALK.
NOD-Proteindesign.Andreas Heddergott/TUM.jpg
Certest
Consilium